Maravai LifeSciences HoldingsMRVI -1.79%62 Days Inventory is 114.94 as of Mar. 2026, which is 6% above its 10-year median of 108.89. GuruFocus rates MRVI with a GF Score™ of 62/100 and a GF Value™ of $3.82 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 638 Biotechnology companies, Maravai LifeSciences Holdings ranks better than 68.65% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Maravai LifeSciences Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maravai LifeSciences Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.61.
Maravai LifeSciences Holdings (NAS:MRVI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Maravai LifeSciences Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maravai LifeSciences Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Maravai LifeSciences Holdings Days Inventory Related Terms
Maravai LifeSciences Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings Days Inventory Chart
MRVI vs LBRX, SLDB, JANX: Days Inventory Comparison
For the Biotechnology subindustry, Maravai LifeSciences Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maravai LifeSciences Holdings Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Maravai LifeSciences Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings (MRVI) has a Days Inventory of 114.94 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Maravai LifeSciences Holdings and its competitors. This is near median its historical median of 108.89. Over the past decade, Maravai LifeSciences Holdings' Days Inventory has ranged from 77.83 to 122.75. According to the industry distribution chart, Maravai LifeSciences Holdings ranks #200 out of 638 companies in the Biotechnology industry, placing it in the top 31.3%.
Is Maravai LifeSciences Holdings' Days Inventory too high?
Maravai LifeSciences Holdings' current Days Inventory of 114.94 is near median its 10-year median of 108.89. Over the past 10 years, this metric has ranged from a low of 77.83 to a high of 122.75. The Biotechnology industry median Days Inventory is 183.88. Maravai LifeSciences Holdings' value of 114.94 is 37.5% below this industry median. Based on the distribution chart, Maravai LifeSciences Holdings ranks #200 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Days Inventory compare to LBRX and SLDB?
According to the Biotechnology industry distribution chart, Maravai LifeSciences Holdings ranks #200 out of 638 companies for Days Inventory. This puts Maravai LifeSciences Holdings in the upper half of its industry. The industry median Days Inventory is 183.88. Maravai LifeSciences Holdings' value of 114.94 is 37.5% below this benchmark. Historically, Maravai LifeSciences Holdings' own Days Inventory has ranged from 77.83 to 122.75 over the past decade. While the company's 10-year median is 108.89 vs. the industry median of 183.88, Maravai LifeSciences Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maravai LifeSciences Holdings's current Days Inventory of 114.94 is 37.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Maravai LifeSciences Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maravai LifeSciences Holdings's current Days Inventory is 114.94, which is near median its own 10-year median of 108.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings (MRVI) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.82, compared to a current price of $6.04 — trading 58.1% above its estimated fair value. The current Days Inventory is 114.94, which is near median its 10-year median of 108.89 and 37.5% below the Biotechnology industry median of 183.88. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MRVI), the current Days Inventory is 114.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maravai LifeSciences Holdings (MRVI) Overvalued in 2026?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued.
The current stock price of $6.04 is trading 58.1% above its estimated GF Value™ of $3.82.
GuruFocus considers Maravai LifeSciences Holdings to be Significantly Overvalued.
Key valuation signals for MRVI:
Days Inventory: 114.94 (near median its 10-year median of 108.89)
GF Value™: $3.82 vs. price of $6.04 (58.1% above fair value)
Industry Position: 37.5% below the Biotechnology median (#200 of 638)
No single metric tells the full story. See the MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score
Get the complete analysis for MRVI
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRVI has been successfully added to your 
